Peer-Reviewed Publications from the Founding of the TB PE & RU in 1998 to the Present

Journals

(*First author was a Fellow/Resident or other trainee/colleague under supervision)

  1. Long R, Maycher B, Dhar A, Manfreda J, Hershfield E, Anthonisen A.  Pulmonary Tuberculosis Treated with Directly Observed Therapy: Serial Changes in Lung Structure and Function.  CHEST 1998;113:933-43.
  2. Long R, Maycher B.  Check-Valve Pneumatocele Formation Following Fully Treated Tuberculosis.  Can Assoc Radiol J  1998;49:197-99.
  3. Sznajder JI, Nahum A, Hansen D, Long GR, Wood LDH.  Volume recruitment and oxygenation in pulmonary edema:  A comparison between HFOV and CMV.  J Crit Care  1998;13:126-135.
  4. * Arvanitakis Z, Long R, Hershfield E, Manfreda J, Kabani A, Kunimoto D, Power C.  M. tuberculosis Molecular Variation in CNS Infection.  Evidence of Strain Dependent Neurovirulence.  Neurology 1998;50:1827-32.
  5. Long R, Njoo H, Hershfield E.  The Epidemiology of Tuberculosis in Canada: Implications for Diagnosis and Treatment.  CMAJ  1999;160:1185-90.
  6. Long R, Cowie R.  Pulmonary Tuberculosis:  Making a Timely Diagnosis. CMAJ  1999;160:1344-48
  7. Long R, Guzman R, Greenberg H, Safneck J, Hershfield E.  Tuberculous mycotic aneurysm of the aorta:  Review of Published Medical and Surgical Experience.   CHEST  1999;115:522-531.
  8. * Bahammam A, Choudhri S, Long R.  The validity of acid-fast smears of gastric aspirates as an indicator of pulmonary tuberculosis.  Int J Tuberc Lung Dis  1999;3:62-67.
  9. * Bahammam A, Choudhri S, Long R. Utility of gastric aspirates in screening for pulmonary tuberculosis in high risk subjects:  The Manitoba Experience.  Can J Infect Dis  1999;10:69-73.
  10. Long R, Light B, Talbot J.   The mycobacteriocidal action of exogenous nitric oxide.   Antimicrob Agents Chemother  1999;43:403-5.
  11. Long R, Nobert E, Chomyc S, van Embden J, McNamee C, Rey Duran R, Talbot J, Fanning A.  Transcontinental spread of multidrug-resistant Mycobacterium bovis.  Am J Respir Crit Care Med 1999;159:2014-17.
  12. * Hersi A, Elwood K, Cowie R, Kunimoto D, Long R.  Multidrug-Resistant Tuberculosis in Western Canada (1989-98).  Can Respir J  1999;6:155-60.
  13. Long R, Scalcini M.  Is treatment of WHO “category 1” tuberculosis with “2 HRZE/6 HE” a defensible practice?  Int J Tuberc Lung Dis  1999;3:747-8.
  14. * Maycher B, O'Connor R, Long R. CT Abnormalities in M. Avium Complex Lung Disease Include the Mosaic Pattern of Reduced Lung Attenuation.  Can Assoc Radiol J   2000;51:93-102.
  15. * Farzad E, Holton D, Long R, FitzGerald M, Njoo H, Laszlo A, Fanning A, Hershfield E, Hoeppner V, Allen E.  Drug Resistance Study of Mycobacterium tuberculosis in Canada.  Can J Public Health 2000; 91:366-70.
  16. Long R, Chomyc S, Der E, Sitar D S. “Pseudo” treatment failure of pulmonary tuberculosis in association with a tuberculoma.  Can Respir J  2000;7:79-83.
  17. Long R.  Drug-resistant tuberculosis.  CMAJ  2000;163:425-8.
  18. Long R, Scalcini M.  More on the question of optimal chemotherapy in the presence of isoniazid resistance.  Int J Tuberc Lung Dis  2000;4:890-4.
  19. Long R.  Tuberculosis, the CLA/CTS and the new millennium (editorial) Can Respir J 2000;7:24-5.
  20. Long R.   Introducing the 5th edition of the Canadian Tuberculosis Standards (editorial) Can Respir J2000;7:449-501.
  21. Heywood N, Kawa B, Long R, Njoo H, Panaro L, Wobeser W, and the Canadian Tuberculosis Committee.  Guidelines for the investigation and follow-up of individuals who were placed under surveillance for tuberculosis after arrival in Canada.  CCDR  2001;27(No.19):157-65 
  22. Long R, Fanning A, McNamee C, Barrie J, Puttagunta L.  Medical versus surgical treatment of a primary tuberculous pleural peel.  Can Respir J  2001;8:449-53.
  23. Long R, Chui L, Kakulphimp J, Zielinski M, Talbot J, Kunimoto D.  Post sanatorium pattern of antituberculous drug resistance in the Canadian-born population of western Canada: Effect of outpatient care and immigration.  Am J Epidemiol  2001; 153: 903-11.
  24. Long R, Smear-negative pulmonary tuberculosis in industrialized countries (editorial).  CHEST2001;120:330-4.
  25. Long R, Zielinski M, Kunimoto D, Manfreda J. The emergency department is a determinant point of contact of tuberculosis patients prior to diagnosis.  Int J Tuberc Lung Dis 2002;6:332-9.
  26. Long R, Sutherland K, Kunimoto D, Cowie R, Manfreda J. The Epidemiology of tuberculosis among foreign-born persons in Alberta, Canada, 1989-1998: Identification of high risk groups.  Int J Tuberc Lung Dis  2002;6:615-21.
  27. Long R.  Tuberculosis Control in Alberta: a federal, provincial and regional public health partnership.Can J Public Health  2002;93:264-66. 
  28. Long R, Houston S, Hershfield E for the Canadian Tuberculosis Committee.  Recommendations for the screening and prevention of tuberculosis (TB) in human immunodeficiency virus (HIV) patients and the screening for human immunodeficiency virus in tuberculosis patients and their contacts.  CCDR 2002;28:1-6. 
  29. Long R, Houston S, Hershfield E for the Canadian Tuberculosis Committee.  Recommendations for the screening and prevention of tuberculosis (TB) in human immunodeficiency virus (HIV) patients and the screening for human immunodeficiency virus in tuberculosis patients and their contacts.  CMAJ2003;169:789-91. 
  30. Long R, Gardam M.  Tumour necrosis factor-α inhibitors and the reactivation of latent tuberculosis infection.  CMAJ  2003:168:1153-5. 
  31. Long R, Bochar K, Chomyc S, Talbot J, Barrie J, Kunimoto D, Tilley P.  Relative versus absolute non-contagiousness of respiratory tuberculosis on treatment.  Infect Control Hosp Epidemiol2003;24:831-38. 
  32. Gardam M, Keystone EC, Menzies R, Skamene E, Long R, Vinh D.  Anti-TNF agents and tuberculosis: mechanisms of action and clinical management.  Lancet - Infect Dis  2003;3:148-155. 
  33. Long R.  New biologic therapies and the risk of tuberculosis in the elderly.  Geriatrics and Aging2003;6:29-34.
  34. Heywood N, Kawa B, Long R, Njoo H, Panaro L, Wobeser W, on behalf of the Immigration Subcommittee of the Canadian Tuberculosis Committee.  Guidelines for the investigation and follow-up of individuals who were placed under surveillance for tuberculosis after arrival in Canada: A summary.  CMAJ 2003;168:1563-65.
  35. Long R, Whittaker D, Russell K, Kunimoto D, Reid R, Fanning A, Nobert E, Melenka L, Yacoub W, Bhargava R.  Pediatric tuberculosis in Alberta First Nations (1991-2000).  Outbreaks and the protective effect of bacille Calmette-Guérin (BCG) vaccine.  Can J Public Health 2004;95:249-255. 
  36. Kunimoto D, Sutherland K, Manfreda J, Wooldrage K, Fanning A, Chui L, Long R.  Transmission characteristics of tuberculosis in the foreign-born and Canadian-born population of Alberta, Canada.  Int J Tuberc Lung Dis 2004;8:1213-20. 
  37. Long R.  Tuberculosis and malnutrition (editorial).  Int J Tuberc Lung Dis 2004;8:276-77. 
  38. Long R, Jones D, Talbot J, Mayers I, Barrie J, Hoskinson M, Light B.  Inhaled nitric oxide treatment of patients with pulmonary tuberculosis evidenced by positive sputum smears. Antimicrob Agents Chemother 2005;49:1209-12. 
  39. Long R, Wong E, Barrie J.  Bronchial anthracofibrosis and tuberculosis: CT features before and after treatment.  Am J Roentgenol 2005; 184(3 Suppl):S33-6.
  40. Kunimoto D, Long R.  Tuberculosis – still overlooked as a cause of community acquired pneumonia.  How not to miss it.  In Marrie T, ed.  Community acquired pneumonia:  new facets of an old disease.  Respir Care Clin 2005;11:25-34.
  41. Long R.  Physician experience, public health and the management of tuberculosis. (Commentary)CMAJ.  2006; 175:759-60.
  42. * Jacobs S, Warman A, Roehrig N, Yacoub W, Wijayasinghe C, Richardson R, Benjamin E, Chong H, Manfreda J, Long R.  Mycobacterium tuberculosis infection and disease in First Nation preschool children in Alberta: implications for BCG (bacille Calmette-Guérin) vaccine withdrawal. Can J Public Health. 2007; 98: 116-20
  43. * Yip D, Bhargava R, Yao Y, Sutherland K, Manfreda J, Long R.  Pediatric tuberculosis in Alberta (1990-2004): Epidemiology and case characteristics.  Can J Public Health, 2007; 98:276-80.
  44. Gardam M, Kunimoto D, Long R, Menzies D, Pai M.  The Canadian Tuberculosis Advisory Committee Statement on the use of Interferon Gamma Release Assays (IGRA).  CCDR, 1 November 2007; 33:ACS 10
  45. Long R, Boffa J. Why internationally adopted children should be screened for tuberculosis. (Commentary) CMAJ 2007; 177:172-3
  46. Long R, Ellis E.  Introduction to the 6th Edition of the Canadian Tuberculosis Standards (Editorial)  Can Respir J and Can J Inf Dis Med Microbiol, 2007;14:327-328 and 2007;18:283-284 
  47. Long R.  The Canadian Lung Association/Canadian Thoracic Society and Tuberculosis Prevention and Control. Can Respir J 2007;14:427-431
  48. Long R, Barrie J, Stewart K, Peloquin C.  Treatment of tuberculous empyema with simultaneous oral and intrapleural antituberculosis drugs. Can Respir J. 2008; 15:241-43
  49. * Lee MC, Takaya S, Long R, Joffe M.  Respiratory fit testing: Does it ensure the protection of healthcare workers against respirable particles carrying pathogens?  Infect Control Hosp Epidemiol2008; 12:1449-1156 
  50. Menzies D, Long R, Trajman A, Dion M Yang J, Al Jahdali H, Memish Z, Khan K Gardam M, Hoeppner V, Schwartzman K.  Adverse events with 4 months rifampin or 9 months isoniazid as therapy for latent TB infection:results of a randomized trial. Ann Int Med 2008; 149:689-697 
  51. Pai M, Gardam M, Haldane, Kitai I, Kunimoto D, Long R, Menzies D, Morshed M, Ward H, Wobeser W. Updated recommendations on interferon gamma release assays for latent tuberculosis infection.  CCDR2008; 34:AC5-6 
  52. *  Sturtevant D, Preiksaitis J, Singh A, Houston S, Gill J, Predy G, Fisher D, Senthilselvan A,  Manfreda J, Boffa J, Long R.  The feasibility of using an ‘opt-out’ approach to achieve HIV testing of tuberculosis patients in Alberta. Can J Public Health 2009; 100:116-20 
  53. Long R, Chong H, Hoeppner V, Shanmuganathan H, Kowalewska-Grochowska K, Shandro C, Manfreda J, Senthilselvan A, Elzainy A, Marrie T.  Empiric treatment of community acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis.  Clin Inf Dis 2009; 48: 1354-1360 
  54. Slupsky CM, Rankin KN, Fu H, Chang D, Rowe BH, Charles PGP, McGeer A, Low D, Long R, Kunimoto D, Sawyer MB, Fedorak RN, Admko DJ, Saude EJ, Shah SL, Marrie TJ.  Pneumococcal pneumonia: Potential for etiologic diagnosis through a urinary metabolic profile. J Protesome Res http://pubs.acs.org/doi/abs/10.1021/pr9006427?prevSearch=%255Bauthor%253A%2BRichard%2BLong%255D&searchHistoryKey= 
  55. Kunimoto D, Der, E, Beckon A, Cabrita L, Egedahl M, Alexander M, Beatch A, Williams G, Tyrrell G, Ahmed R, Brown N, Long R. Use of the Quantiferon®-TB Gold test to confirm latent TB infection in a Canadian tuberculosis clinic. Int J Tuberc Lung Dis 2009; 13: 726-730 
  56. Xu T, Mandal M, Long R, Basu A. Gradient vector flow based active shape model for lung field segmentation in chest radiographs. 31st annual International IEEE EMBS Conference. Paper No. 789 
  57. Long R, Beatch A, Lee MC, Cheung-Lee M, Wasel N. Lupus Vulgaris Occurring in a Locus Minoris Resistentiae. J Cutaneous Med and Surgery 2009; 13(6):313-316 
  58. * Aspler A, Chong H, Kunimoto D,Chui L, Boffa J, Long R. Sustained intra- and inter-jurisdictional transmission of tuberculosis within a mobile, multi-ethnic social network: Lessons for tuberculosis elimination Can J Public Health 2010; 101: 205-209
  59. * Hwang J, Puttagunta L, Green F, Shimanovsky A, Barrie J, Long R. Bronchical anthracofibrosis and tuberculosis in immigrants to Canada from the Indian subcontinent. Int J Tuberc Lung Dis 2010; 14: 231-237 
  60. Aspler A, Long R, Trajiman A, Dion M-J, Khan K, Schwartzman K, Menzies D. Health system costs with 4 months rifampin or 9 months isoniazid as therapy for latent TB infection: results from a randomized trial. Thorax 2010; 65: 582-587 
  61. * Webster D, Long R, Shandro C, Pettipas J, Davidson R, Fanning A.  Fluoroquinolone resistance in renal isolates of Mycobacterium tuberculosis.  Int J Tuberc Lung Dis 2010; 14: 217-222 
  62. Long R, Boffa J. High HIV-TB Co-infection Rates in Marginalized Populations: Evidence from Alberta in Support of Screening TB Patients for HIV (Commentary) Can J Public Health 2010; 101: 202-204 
  63. Trajman A, Zylberberg D, Dion MG, Al-Otaibi B, Long R, Menzies D. Factors associated with treatment compliance in a randomized trial of treatment of latent tuberculosis infection. Int J Tuberc Lung Dis2010; 14: 551-559 
  64. Olsen S, Long R, Tyrrell G, Kunimoto D. Induced sputum for the diagnosis of pulmonary tuberculosis: Is it effective in clinical practice. Can Respir J 2010;  http://www.pulsus.com/journals/abstract.jsp?sCurrPg=journal&jnlKy=4&atlKy=9622&isuKy=931&spage=1&isArt=t 
  65. * Boffa J, King M, McMullin K, Long R. A process for the inclusion of Aboriginal people in health research: Lessons from the Determinants of TB Transmission Project. Soc Sci Med 2011;72:733-738 
  66. * Elamy H, Far B, Mandel M, Basu A, Cheng I, Long R. An intelligent CAD system for automated detection of pulmonary tuberculosis on chest radiograph and CT thorax: a road map. IEEE CCECE Conference Paper No.1569277319
  67. * Elamy H, Far B, Long R. An intelligent multi-agent system for automated detection and diagnosis of active tuberculosis on chest radiographs SEKE Paper No. 285: 485 - 498
  68. * Langlois-Klassen D, Wooldrage K, Manfreda J, Sutherland K, Ellis E, Phypers M, Gushulak B, Long R. Piecing the puzzle together: foreign-born tuberculosis in an immigrant-receiving country. Eur Resp J 2011 Oct;38(4):895-902 
  69. * Jacobs S, Warman A, Richardson R, Yacoub W, Lau A, Whittaker D, Cockburn S, Verma G, Boffa J, Tyrrell G, Kunimoto D, Manfreda J, Langlois-Klassen D, Long R. The tuberculin skin test is unreliable in school children  BCG–vaccinated in infancy and at low risk of tuberculosis infection. Pediatr  Infect Dis J 2011 Sep;30(9):754-8 
  70. Pepperell C, Granka J, Alexander D, Behr M, Chui L, Gordon J, Guthrie M, Jamieson F, Langlois-Klassen D, Long R, Nguyen D, Wobeser W, Feldman M.  Dispersal of Mycobacteriumtuberculosis via the Canadian fur trade. Proc Natl Acad Sci (USA) 2011 April doi: 10.1073/pnas.1016708108
  71. * Jensen M, Lau A, Langlois-Klassen D, Boffa J, Manfreda J, Long R.  Eliminating Tuberculosis: A population-based study of TB epidemiology and innovative service delivery in Canada. Int J Tuberc Lung Dis 2012;16:43-49
  72. Long R, Hoeppner V, Orr P, Ainslie M, King M, Abonyi S, Mayan M, Kunimoto D, Langlois-Klassen D, Heffernan C, Lau A, Menzies D.  Marked disparity in the epidemiology of tuberculosis among Aboriginal peoples on the Canadian prairies: the challenges and opportunities. Can Respir J ( In Press)
  73. * McMullin K, Abonyi S, Mayan M, Orr P, Lopez-Hille C, Boffa J, Long R. Evoking ‘Old Keyam’ as a response to the disproportionate experience of tuberculosis among Aboriginal Peoples of the Canadian Prairies. J Aboriginal Health 2012;(9): 30-40.
  74. * Langlois-Klassen D, Kunimoto D, Saunders D, Chiu L, Boffa J, Menzies D, Long R. A population based cohort study of Mycobacterium tuberculosis Beijing strains: an emerging public health threat in an immigrant-receiving country. PLoS ONE  2012 Doi: 10.1371/journal.pone.0038431  
  75. * Langlois-Klassen D, Senthilselvan A, Kunimoto D, Saunders LD, Menzies D, Long R. Transmission of Beijing strains of M. tuberculosis in a low incidence setting: time to silence the alarms? Emerg Infect Dis ( In Press)
  76. * Xu T, Mandal M, Long R, Cheng I, Basu A. An edge-region force guided active shape approach for automatic lung field detection in chest radiographs. Compt Med Imaging Graph (2012), http://dx.doi.org/10.1016/j.compmedimag.2012.04.005
  77. Long R, Langlois-Klassen D. Increase in multidrug-resistant tuberculosis (MDR-TB) in Alberta among foreign-born persons: implications for tuberculosis management. Can J Public Health 2013; 104(1): e22-e27
  78. * Xu T, Cheng I, Long R, Mandal M. Novel coarse-to-fine dual scale technique for tuberculosis cavity detection in chest radiographs. Eurasip Journal on Image and Video Processing 2013, 2013:3.http://jivp.eurasipjournals.com/content/2013/1/3
  79. * Minion J, Gallant V, Wolfe J, Jamieson F, Long R. Multidrug and extensively drug-resistant tuberculosis in Canada 1997-2008: demographic and disease characteristics. PLoS ONE (2013), http://dx.plos.org/10!1371/journal.plone.0053466
  80. *Moffatt J, Mayan M, Long R.Sanatoriums and the Canadian Colonial legacy: The Untold Story of Tuberculosis Treatment. Qual Health Res 2013;23(12):1591-99
  81. *Xu T, Cheng I, Long R, Mandal M. Computer-aided Detection of Acinar Shadows in Chest Radiograph. ICTACT Journal on Image and Video-Processing 2013;3(4):593-604
  82. Long R, Lau A, Warman A, Langlois-Klassen D. Tuberculosis outbreaks in Canada: an historical perspective with emphasis on community outbreaks in First Nations (North American Indians). Public Health Action (Submitted)
  83. *Varughese M, Langlois-Klassen D, Long R, Li M. Preventing tuberculosis in the foreign-born population of Canada: A Mathematical modeling study. Int J Tuberc Lung Dis (Submitted)
  84. Rozmus J, Junker A, Thibodeau ML, Grenier D, Turvey SE, Yacoub W, Embree J, Haddad E, Langley J, Ramsingh R, Singh V-A, Long R, Schultz KR. Severe Combined Immunodeficiency (SCID) in Canadian children: A prospective National Surveillance Study and the case for newborn screening. CMAJ 2013. DOI 10.1007/s 10875-013-9952-8
  85. *Dhawan V, Langlois-Klassen D, Lau A, Kunimoto D, Bhargava R, Chui L, Long R. The Transmission dynamics of pediatric tuberculosis in a province of Canada: The complimentary role of conventional and molecular epidemiology. Int J Tuberc Lung Dis (Submitted)
  86. *Moffat, J, Long R, Mayan M. Taking care of our own: The multifaceted relationship between on-reserve housing and tuberculosis occurrence. Pimatisiwin: A Journal of Aboriginal and Indigenous Community Health  2013;11(3):555-564
  87. *Long R, Niruban J, Heffernan C, Ahmed R, Fisher D, Cooper R, Langlois-Klassen D."Opt-out" HIV testing of tuberculosis patients in Canada: a 10-year population based experience. PLos One (Submitted)



Book Chapters

  1. Njoo H, Long R.  The epidemiology of tuberculosis in Canada.  In: Long R, ed. Canadian Tuberculosis Standards 5th ed.  Ottawa: Health Canada and Canadian Lung Association, 2000:3-14.
  2. Long R, Jessamine P.  Transmission and pathogenesis of tuberculosis.  In: Long R, ed.  Canadian Tuberculosis Standards 5th ed.  Ottawa: Health Canada and Canadian Lung Association, 2000:31-44.
  3. Long R. Nonrespiratory (Extrapulmonary) Tuberculosis.  In: Long R, ed.  Canadian Tuberculosis Standards 5th ed.  Ottawa: Health Canada and Canadian Lung Association, 2000:67-81.
  4. Long R, Avendano M.  Drug-resistant tuberculosis.  In: Long R, ed.  Canadian Tuberculosis Standards 5th ed.  Ottawa: Health Canada and Canadian Lung Association, 2000:111-25.
  5. Houston S, Schwartzman K, Brassard P, Avendano M, Long R.  Tuberculosis in patients with human immunodeficiency virus.  In: Long R, ed.  Canadian Tuberculosis Standards 5th ed.  Ottawa: Health Canada and Canadian Lung Association, 2000:141-51.
  6. Long R, Schwartzman K.  Transmission and pathogenesis of tuberculosis.  In: Long R, Ellis E, eds., Canadian Tuberculosis Standards 6th edition.  Ottawa: Health Canada and Canadian Lung Association, 2007: 37-52
  7.  Cook V, Long R.  Non-respiratory tuberculosis.  In: Long R, Ellis E, eds., Canadian Tuberculosis Standards 6th edition.  Ottawa: Health Canada and Canadian Lung Association, 2007: 92-113
  8. Long R, Avendano M, Whitehead L.  Drug-resistant tuberculosis. In: Long R, Ellis E, eds., Canadian Tuberculosis Standards 6th edition.  Ottawa: Health Canada and Canadian Lung Association, 2007: 146-181
  9. Kitai I, Malloy P, Kowalczyk A, Long R.  Pediatric tuberculosis.  In:  Long R, Ellis E, eds. Canadian Tuberculosis Standards 6th edition.  Ottawa: Health Canada and Canadian Lung Association, 2007: 182-199
  10. Long R, Schwartzman K. The Pathogenesis and Transmission of Tuberculosis. In Menzies D, ed.Canadian Tuberculosis Standards, 7th edition., Ottawa. Canadian Lung Association and Public Health Agency of Canada, 2013.
  11. Long R, Avendano M, Kunimoto D. Drug-resistant Tuberculosis. In Menzies D, ed. Canadian Tuberculosis Standards, 7th edition, Ottawa. Canadian Lung Association and Public Health Agency of Canada, 2013.
  12. Alvarez G, Orr P, Wobeser W, Cook V, Long R. Tuberculosis Prevention and Care in First Nations, Inuit and Métis Peoples. In Menzies D, ed. Canadian Tuberculosis Standards, 7th edition, Ottawa. Canadian Lung Association and Public Health Agency of Canada, 2013.


Books

  1. Long R.  ed.  Canadian Tuberculosis Standards 5th ed.  Ottawa: Health Canada and Canadian Lung Association, 2000.
  2. Long R, Ellis E,  eds.  Canadian Tuberculosis Standards 6th ed.  Ottawa: Health Canada and Canadian Lung Association, 2007.
  3. Menzies D ed; Ellis E, Long R, Pai M, Wong T, Associate eds. Canadian Tuberculosis Standards 7thed. Ottawa: Canadian Lung Association and Public Health Agency of Canada, 2013.